Genetic screening, health care and the insurance industry: Should genetic information be made available to insurers?

European Journal of Health Economics

Volumn 5, Issue 2, 2004, Pages 116-121

  Ossa, Diego F ^a   Towse, Adrian ^b  

^a ICON PLC   (United Kingdom)

^b Office of Health Economics   (United Kingdom)

Author keywords

Europe; Genetic screening; Health care sector; Insurance; Models, economic

Indexed keywords

ARTICLE; ECONOMIC ASPECT; EUROPE; GENETIC PROCEDURES; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; HEALTH INSURANCE; PRIORITY JOURNAL;

GENETICS AND REPRODUCTION;

GENETIC PRIVACY; GENETIC SCREENING; HUMANS; INSURANCE CARRIERS; MODELS, ECONOMIC;

EID: 3042581996     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. McGleenan T (1999) Genetic testing and the insurance industry. In: Genetics and insurance, 1st edn. BIOS: Oxford, pp. S7-73
2. O'Neill O (1998) Insurance and genetics: the current state of play. Mod Law Rev 61:716-723
3. Zimmerman SE (1998) The use of genetic tests and genetic information by life insurance companies: does this differ from the use of routine medical information? Genet Test 2:3-8
4. Akerlof GA (1970) The Market for "lemons": quality, uncertainty and the market mechanism. Q J Econ 89:488-500
5. Schöffski O (2002) Genetic testing and the health care system. Eur J Health Econ 3:73-76
6. McGleenan T (1999) Insurance, genetics and the law. In: Genetics and insurance, 1st edn. BIOS: Oxford, pp 7S-9S
7. Macdonald AS (1999) Modelling the impact of genetic testing. N Am Actuarial J 3:83-101
8. Macdonald AS (1997) How will improved forecasts of individual lifetimes affect underwriting? Philos Trans R Soc Lond B 3S2:1067-1075
9. Macdonald AS (2002) Genetics and health costs: some actuarial models. La Probability Risk 1:97-118
10. Fenn P (2000) Genetic tests and adverse selection in health insurance: some simulation results. Presented at the 22nd UK Insurance Economists' Conference, March
11. Gaulding J (1995) Race, sex and genetic discrimination in insurance. Cornell L Rev 80:1646-1694
12. Morrison PJ, Steel CM, Vasen HF et al (2000) Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe. Dis Markers 15-:159-165
13. Rosén E (1999) Genetic information & genetic discrimination how medical records vitiate legal protection. A comparative analysis of international legislation and policies. Scand J Public Health 27:166-172
14. Murthy A, Dixon A, Mosialos E (2001) Genetic testing and insurance. J R Soc Med 94:57-60
15. Rimoin DL, O'Connor JM, Pyeritz RE (1997) Nature and frequency of genetic disease in Emery and Rimoin's principles and practice of medical genetic, 3rd edn. Churchill Livingstone: London, pp 31-34
16. Hauser G, Jenish A (1999) The implications of genetic regulation for insurance: the Austrian experience. In: Genetics and insurance, 1st edn. BIOS: Oxford, pp 97-104